Loading...
Loading...
CST Brands
CST is expected to report its Q1 earnings at $0.19 per share on revenue of $3.07 billion.
Fossil Group
FOSL is projected to post its Q1 earnings at $1.17 per share on revenue of $771.60 million.
Take-Two Interactive Software
TTWO is expected to post its Q4 earnings at $0.10 per share on revenue of $202.51 million.
CTI Industries
CTIB is estimated to report its Q1 earnings at $0.02 per share on revenue of $15.75 million.
URS
URS is projected to post its Q1 earnings at $0.68 per share on revenue of $2.68 billion.
LATAM Airlines Group SA
LFL is expected to post its Q1 earnings at $0.20 per share on revenue of $3.42 billion.
Gladstone Investment
GAIN is projected to post its Q4 earnings at $0.17 per share on revenue of $8.90 million.
First Horizon National
FHN is expected to report its Q2 earnings at $0.17 per share on revenue of $286.98 million.
Synacor
SYNC is estimated to post a Q1 loss at $0.05 per share on revenue of $24.53 million.
Diana Containerships
DCIX is projected to report its Q1 earnings at $0.01 per share on revenue of $13.22 million.
Intrawest Resorts Holdings
SNOW is expected to post its Q3 earnings at $2.69 per share on revenue of $294.89 million.
Cosan
CZZ is estimated to post its Q1 earnings at $0.16 per share.
ViaSat
VSATLoading...
Loading...
is projected to post its Q4 earnings at $0.11 per share on revenue of $348.98 million.
Biodel
BIOD is expected to post a Q1 loss at $0.24 per share.
First Majestic Silver
AG is estimated to post its Q1 earnings at $0.10 per share on revenue of $63.35 million.
Dr. Reddy's Laboratories
RDY is expected to report its Q4 earnings at $0.52 per share.
YuMe
YUME is estimated to post a Q1 loss at $0.15 per share on revenue of $35.36 million.
Vertex Energy
VTNR is projected to report its Q1 earnings at $0.03 per share on revenue of $42.48 million.
Idera Pharmaceuticals
IDRA is estimated to report a Q1 loss at $0.08 per share on revenue of $3.00 thousand.
USA Technologies
USAT is projected to report its Q3 earnings at $0.00 per share on revenue of $10.63 million.
P&F Industries
PFIN is expected to report its quarterly results.
INSYS Therapeutics
INSY is projected to report its Q1 earnings at $0.28 per share on revenue of $45.63 million.
Loading...
Loading...
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in